Emergent Biosolutions【EBS】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

8.07

買値

売値

出来高

2,438,054

7.82 日の範囲 8.35

1.42 52 週間の範囲 15.10

時価総額

437.266M

前日終値

8.06

始値

7.8833

時刻

8.12

最終取引時間

財務取引量

US$ 19,904,971

VWAP

8.1643

平均取引量 (3 か月)

1,352,150

発行済株式数

54,184,186

配当利回り

PER

-0.58

1 株当たり利益 (EPS)

-14.04

歳入

1.05B

純利益

-760.5M

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.emergentbiosolutions.com

本社

Wilmington, Delaware, USA

設立

Emergent Biosolutions Inc is listed in the Pharmaceutical Preparations sector of the ニューヨーク証券取引所 with ticker EBS. The last closing price for Emergent Biosolutions was US$8.06. Over the last year, Emergent Biosolutions shares have traded in a share price range of US$ 1.42 to US$ 15.10.

Emergent Biosolutions currently has 54,184,186 shares in issue. The market capitalisation of Emergent Biosolutions is US$436.72 million. Emergent Biosolutions has a price to earnings ratio (PE ratio) of -0.58.

全体の流れ

ブルリッシュ

ネットプレミアム

26k

Calls / Puts

100.00%

買い / 売り

100.00%

OTM / ITM

0.00%

Sweeps比率

0.00%

Form 4 - Statement of changes in beneficial ownership of securities

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.695	-7.92926411865	8.765	9.03	8.01	1098589	8.47198567	CS
4	-1.33	-14.1489361702	9.4	10.43	8.01	902866	9.06603025	CS
12	0.74	10.0954979536	7.33	12.73	7.03	1352150	9.25175936	CS
26	1.84	29.5345104334	6.23	15.1	5.25	2310397	9.06383314	CS
52	5.62	229.387755102	2.45	15.1	1.42	3071668	5.49929523	CS
156	-36.64	-81.9503466786	44.71	52.77	1.42	1828630	9.13103575	CS
260	-45.83	-85.0278293135	53.9	137.61	1.42	1363712	22.22200176	CS

EBS - Frequently Asked Questions (FAQ)

What is the current Emergent Biosolutions share price?

The current share price of Emergent Biosolutions is US$ 8.07

How many Emergent Biosolutions shares are in issue?

Emergent Biosolutions has 54,184,186 shares in issue

What is the market cap of Emergent Biosolutions?

The market capitalisation of Emergent Biosolutions is USD 436.72M

What is the 1 year trading range for Emergent Biosolutions share price?

Emergent Biosolutions has traded in the range of US$ 1.42 to US$ 15.10 during the past year

What is the PE ratio of Emergent Biosolutions?

The price to earnings ratio of Emergent Biosolutions is -0.58

What is the cash to sales ratio of Emergent Biosolutions?

The cash to sales ratio of Emergent Biosolutions is 0.42

What is the reporting currency for Emergent Biosolutions?

Emergent Biosolutions reports financial results in USD

What is the latest annual turnover for Emergent Biosolutions?

The latest annual turnover of Emergent Biosolutions is USD 1.05B

What is the latest annual profit for Emergent Biosolutions?

The latest annual profit of Emergent Biosolutions is USD -760.5M

What is the registered address of Emergent Biosolutions?

The registered address for Emergent Biosolutions is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Emergent Biosolutions website address?

The website address for Emergent Biosolutions is www.emergentbiosolutions.com

Which industry sector does Emergent Biosolutions operate in?

Emergent Biosolutions operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
VNCEVince Holding Corp	US$ 4.70 (69.06%)	1.06M
SRFMSurf Air Mobility Inc	US$ 3.33 (23.79%)	367.21k
BBBlackBerry Limited	US$ 3.685 (23.66%)	40.27M
ALURAllurion Technologies Inc	US$ 0.3439 (22.87%)	702.83k
CLWClearWater Paper Corporation	US$ 30.26 (22.46%)	3.5M
IIPRInnovative Industrial Properties Inc	US$ 73.50 (-22.91%)	3.15M
KUKEKuke Music Holding Limited	US$ 0.31 (-20.51%)	61.21k
NVONovo Nordisk	US$ 85.00 (-17.83%)	53.78M
CANGCango Inc	US$ 5.08 (-11.81%)	2.27M
BNEDBarnes and Noble Education Inc	US$ 9.965 (-10.31%)	1.52M
QBTSD Wave Quantum Inc	US$ 6.638 (4.21%)	124.23M
PFEPfizer Inc	US$ 26.36 (2.29%)	111.08M
APOApollo Global Management Inc	US$ 171.03 (0.83%)	94.47M
TAT&T Inc	US$ 22.75 (0.80%)	88.77M
FFord Motor Company	US$ 9.885 (1.49%)	87.61M